Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin Penetration in Hepatic Cysts (PENTAC)
NCT02368015Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Open-label, single-arm trial of cefazolin in infectious hepatic cyst (IHC), sponsored by Radboud University Medical Center. Primary endpoint: Hepatic cyst penetration of cefazolin. Started Dec 2014; status: completed.
02
Drugs
cefazolin
03
Conditions
infectious hepatic cyst (IHC)
Beyond the preview
Go deeper on NCT02368015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368015.